Elevance Health Q2 Adjusted Earnings Fall, Revenue Rises; Raises Full-Year Adjusted EPS Outlook

Elevance Health (ELV) reported Q2 adjusted earnings Wednesday of $7.45 per diluted share, down from $8.84 a year earlier. Analysts polled by FactSet expected $6.21. Operating revenue for the quarter ended June 30 was $49.83 billion, up from $49.42 billion a year earlier. Analysts surveyed by FactSet expected $48.84 billion. The company raised its 2026 adjusted EPS outlook to at least $27 from a prior outlook of $26.75. Analysts polled by FactSet expect $26.87. Elevance Health shares were up 3% in premarket activity.